Unique ID issued by UMIN | UMIN000008730 |
---|---|
Receipt number | R000010239 |
Scientific Title | Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA) |
Date of disclosure of the study information | 2012/10/01 |
Last modified on | 2019/08/28 15:34:19 |
Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)
AQUALA study
Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)
AQUALA study
Japan |
Hip disorders including osteoarthritis
Orthopedics |
Others
NO
Assessment of effectiveness and safety of the Aquala liner in patients who have the Aquala liner as an acetabular component of artificial hip joint
Efficacy
Wear of the polyethylene liner
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Ceramic femoral head
Metal femoral head
Not applicable |
75 | years-old | >= |
Male and Female
1) Patients who are indicated for a primary THA, and entered this study on the basis of their agreement to participate in the clinical trial. Patients who are indicated for this surgery on both sides can be included.
2) Patients who have an indication for the Aquala liner with a femoral head of 28 mm or 32 mm in diameter.
3) Patients aged 75 or younger at the time of a written prior consent to participate in this clinical study(no gender selective).
1) Patients who are not indicated for a primary THA
2) Patients with unstable clinical conditions
3) Patients whose weight is over the weight restriction of the femoral components to be used
4) Patients who are difficult to be followed for 5 years after the index surgery
5) Patients who are unable to evaluate their own QOL
6) Patients whose functions of the hip joints are difficult to evaluate due to disorders of other organs such as heart and nervous system
7) Patients who once had an artificial hip joint in the same hip joint
8) Patients who are at high risk of thrombosis or bleeding
9) Patients susceptive to infection
10)Patients receiving the anticancer drug therapy
11)Patients who are evaluated to be unsuitable for the subject of this study by the investigators
760
1st name | Sakae |
Middle name | |
Last name | Tanaka |
Graduate School of Medicine, The University of Tokyo
Orthopaedic Surgery, Sensory and Motor System Medicine, Surgical Sciences
113-8655
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411
tanakas-ort@h.u-tokyo.ac.jp
1st name | Yoshio |
Middle name | |
Last name | Takatori |
Graduate School of Medicine, The University of Tokyo
Div. Science for Joint Reconstruction
113-8655
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411
takatori-orth@umin.ac.jp
Graduate School of Medicine, The University of Tokyo
KYOCERA Corporation
Profit organization
Japan
The University of Tokyo, Clinical Research Review Board
Tokyo 7-3-1, Hongo, Bunkyo-ku
03-5841-0818
ehics@m.u-tokyo.ac.jp
YES
jRCTs032180333
Japan Registry of Clinical Trials
2012 | Year | 10 | Month | 01 | Day |
Unpublished
Terminated
2012 | Year | 07 | Month | 09 | Day |
2012 | Year | 07 | Month | 26 | Day |
2012 | Year | 10 | Month | 01 | Day |
2020 | Year | 09 | Month | 30 | Day |
Reason for discontinuation:Regisetred to another database
Registration database:Japan Registry of Clinical Trials, ID/jRCTs032180333
2012 | Year | 08 | Month | 20 | Day |
2019 | Year | 08 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010239